- Research Centers
- Reproductive Endocrinology Research Center
- Prevention of Metabolic Disorders Research center
- Nutrition and Endocrine Research Center
- Endocrine Physiology Research Center
- Cellular-Molecular Research Center
- Prevention and Treatment of Obesity Research Center
- Endocrine Research Center
- Research Center for Social Determinants of Health
RAPID-ACTING INSULINS
RAPID-ACTING INSULINS
F.Sarvghadi MD
Associate professor of endocrinology.
Research institute for endocrine sciences
Shahid Beheshti University
Of Medical Sciences
AGENDA
- Introduction
- Pharmacokinetic Properties of Insulin
- Molecular Structure & Dosage Forms
- Lispro
- Glulisine
- Aspart
- Comparison between Insulin Regular & Rapid-Acting Insulin in DM1(HbA1C Reduction, rate of Hypoglycemia ,Quality of Life)
- Comparison between Insulin Regular & Rapid-Acting Insulin in DM2(HbA1C Reduction ,rate of Hypoglycemia , Quality of Life)
- Rapid –Acting Insulin in Pregnancy
- Rapid –Acting Insulin in Elderly
- Conclusion
Introduction
- Insulin has been commercially available since the early 1920s and is still the mainstay of therapy for most people with DM worldwide.
- Currently, almost all insulin
used worldwide is of recombinant
human origin or an analogue.
